. 2016 Sep 29;16:758. doi: 10.1186/s12885-016-2797-9

Table 1.

Detailed imaging parameters of the magnetic resonance imaging instruments used in the current investigation

Sonata®	Avanto®	Trio®	Skyra®
T2w^a tra	T2w^a tra	T2w^a tra	T2w^a tra
T1w in/opposed phase ^b tra	T1w in/opposed phase ^b tra	T1w in/opposed phase ^b tra	T1w in/opposed phase ^b tra
Diffusion-weighted imaging tra	Diffusion-weighted imaging tra	Diffusion-weighted imaging tra	Diffusion-weighted imaging tra
4x T1w fs (native, arterial, portal venous, equilibrium) ^c	4x T1w fs (native, arterial, portal venous, equilibrium) ^d	4x T1w fs (native, arterial, portal venous, equilibrium) ^d	4x T1w fs (native, arterial, portal venous, equilibrium) ^d
T1w ^b tra/cor (delayed)	T1w ^b tra (delayed)	T1w ^b tra (delayed)	T1w ^b tra (delayed)

tra transversal, cor coronal

^a T2-weighted half-Fourier acquisition single-shot turbo spin-echo sequence (HASTE)

^b T1-weighted fat-suppressed fast low-angle shot gradient echo sequence (FLASH®)

^c T1-weighted fat-suppressed multi-phase contrast-enhanced series (FL 3d)

^d T1-weighted fat-suppressed multi-phase contrast-enhanced series (VIBE®)